BeOne Medicines AG
F:49BA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BeOne Medicines AG
F:49BA
|
CH |
|
E
|
Eutelsat Communications SA
F:E3B
|
FR |
|
BeOne Medicines AG
NASDAQ:ONC
|
CH |
|
G
|
Gen Digital Inc
DUS:SYM
|
US |
|
Nomura Research Institute Ltd
F:NR7
|
JP |
|
Odfjell SE
F:O7F1
|
NO |
|
Teleperformance SE
F:RCF
|
FR |
|
F
|
Fortune Brands Innovations Inc
DUS:2FB
|
US |
|
COMPUTERSHARE LIMITED
ASX:CPU
|
AU |
|
Premier Miton Group PLC
LSE:PMI
|
UK |
|
Sumitomo Forestry Co Ltd
F:5F6
|
JP |
|
Odfjell SE
F:O7F
|
NO |
|
Galenica AG
OTC:GALNF
|
CH |
|
G
|
Gen Digital Inc
XHAM:SYM
|
US |
|
Yojee Ltd
F:SRC
|
AU |
|
G
|
Gen Digital Inc
SWB:SYM
|
US |
|
Gale Pacific Ltd
ASX:GAP
|
AU |
|
T
|
Teleperformance SE
XMUN:RCF
|
FR |
|
G
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
F:GU5
|
CN |
|
Domino's Pizza Enterprises Ltd
ASX:DMP
|
AU |
|
A
|
Axo Metals Corp
XTSX:AXO
|
CA |
|
Inpex Corp
F:V8W
|
JP |
|
P
|
Prabos Plus as
PSE:PRAB
|
CZ |
|
KDA Group Inc
XTSX:KDA
|
CA |
Bankruptcy Probability
BeOne Medicines AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BeOne Medicines AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
BeOne Medicines AG
SSE:688235
|
228.9B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
454.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
178.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
47.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BeOne Medicines AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BeOne Medicines AG has total debt of 7.4B CNY. This includes both short-term (400.4m CNY) and long-term (7B CNY) debt.
You can find a full breakdown on its Balance Sheet.